The plant-based meat company struck a licensing agreement with bread and pasta maker Equii to create products that pair with ...
The new dietary guidelines call for prioritizing high-quality protein, healthy fats, fruits, vegetables and whole grains.
This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...
Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...
CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...
Proteomics and genomics share the common goal of characterizing biological systems, yet they differ fundamentally in their molecular targets, analytical challenges and interpretive value. Genomics ...
Regeneron Pharmaceuticals (NASDAQ:REGN) announced on Tuesday that a Phase 3 trial for its RNA-based therapy cemdisiran, developed with Alnylam Pharmaceuticals (NASDAQ:ALNY), succeeded in a late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback